PARP Inhibitors: Assessing the Rapidly Evolving Treatment Landscape
AUAUniversity31 Maalis 2021

PARP Inhibitors: Assessing the Rapidly Evolving Treatment Landscape

This educational series is supported by independent educational grants from AstraZeneca and Merck. CME Available: https://auau.auanet.org/node/31198 Based on the documented need from the 2019 AUA global needs assessment in advanced prostate cancer, the AUA has produced a new series of educational offerings for the urologic care team focused on PARP inhibitors (PARPi). The first of three in the series PARP Inhibitors: Assessing the Rapidly Evolving Treatment Landscape will address the latest developments in PARPi treatments and advanced prostate cancer care. Upon completion of this activity, participants will be able to: 1. Review recommended criteria for genetic testing of prostate cancer patients and the options for testing these men. 2. Explain importance of testing for germline pathogenic variants and their implication for utilizing novel targeted therapies such as PARP inhibitors and for cascade testing among patient family members. 3. Identify men with BRCA1/2 pathogenic variants and variants in other key inherited syndromes, regarding their prostate cancer and other cancer risk, and implement strategies for cancer screening and management.

Jaksot(425)

Second Opinion Cases Ask The Guidelines! Recurrent Urinary Tract Infection

Second Opinion Cases Ask The Guidelines! Recurrent Urinary Tract Infection

Moderator(s) A. Lenore Ackerman, MD Cedars-Sinai Medical Center Panelist(s) Toby Chai, MD Professor Yale University School of Medicine Duane Hickling, MD The Ottawa Hospital, The Ottawa Research Ins...

26 Heinä 201928min

AUA2019 072IC Management Of NMIBC - Practical Solutions For Common Problems

AUA2019 072IC Management Of NMIBC - Practical Solutions For Common Problems

Support provided by independent educational grants from AstraZeneca, Bristol-Myers Squibb, Genentech and Merck CME Available: https://auau.auanet.org/node/25249 This course will review the most rece...

19 Heinä 20192h 3min

Manipulating The Androgen Axis | Radionuclide Therapy And Bone Health

Manipulating The Androgen Axis | Radionuclide Therapy And Bone Health

This educational series is supported by independent educational grants from: AbbVie, Astellas and Pfizer, Inc., AstraZeneca, Bayer HealthCare Pharmaceuticals Inc., Genomic Health, Merck, Sanofi Genzy...

16 Heinä 201942min

AUA2019 048IC Novel Agents & Concepts In The Management Of Hormone Naïve & CRPC

AUA2019 048IC Novel Agents & Concepts In The Management Of Hormone Naïve & CRPC

Support provided by independent educational grants from AbbVie, Amgen, Astellas, AstraZeneca, Bristol-Myers Squibb, Genomic Health, Genentech, Merck, Pfizer, Inc. and Sanofi Genzyme CME Available: h...

12 Heinä 20191h 52min

Setting Up a Clinic In The Community Setting | The Role Of Chemotherapy Treatment

Setting Up a Clinic In The Community Setting | The Role Of Chemotherapy Treatment

This educational series is supported by independent educational grants from: AbbVie, Astellas and Pfizer, Inc., AstraZeneca, Bayer HealthCare Pharmaceuticals Inc., Genomic Health, Merck, Sanofi Genz...

9 Heinä 201953min

AUA2019 037IC Help Patients Decide On Prostate Cancer Screening And Treatment

AUA2019 037IC Help Patients Decide On Prostate Cancer Screening And Treatment

Support provided by independent educational grants from AbbVie, Amgen, Astellas, AstraZeneca, Bristol-Myers Squibb, Genomic Health, Genentech, Merck, Pfizer, Inc. and Sanofi Genzyme CME Available: h...

5 Heinä 20191h 46min

Genetic Testing in Advanced Prostate Cancer and Initial Management of Biochemical Recurrence

Genetic Testing in Advanced Prostate Cancer and Initial Management of Biochemical Recurrence

This educational series is supported by independent educational grants from: AbbVie, Astellas and Pfizer, Inc., AstraZeneca, Bayer HealthCare Pharmaceuticals Inc., Genomic Health, Merck, Sanofi Genzy...

2 Heinä 201953min

AUA2019 035IC Contemporary Pharmacotherapy For OAB 2019

AUA2019 035IC Contemporary Pharmacotherapy For OAB 2019

Support provided by an independent educational grant from Allergan, Astellas and Medtronic CME Available: https://auau.auanet.org/node/24584 Instructional Course Director(s) Eric Rovner, MD Medical...

27 Kesä 20191h 54min

Suosittua kategoriassa Koulutus

rss-murhan-anatomia
voi-hyvin-meditaatiot-2
rss-narsisti
psykopodiaa-podcast
rss-niinku-asia-on
rss-vapaudu-voimaasi
adhd-podi
psykologia
rss-duodecim-lehti
rss-rahamania
rss-valo-minussa-2
kesken
rss-uskonto-on-tylsaa
aamukahvilla
koulu-podcast-2
rss-liian-kuuma-peruna
rss-koira-haudattuna
avara-mieli
rss-turun-yliopisto
rss-arkea-ja-aurinkoa-podcast-espanjasta